How much is a share of Correvio worth?
One share of CORV stock can currently be purchased for approximately $0.42. How much money does Correvio Pharma make? Correvio Pharma has a market capitalization of $27.80 million and generates $32.63 million in revenue each year.
Is Correvio Pharma (CRV) a good buy with a negative P/E ratio?
Only 7.30% of the stock of Correvio Pharma is held by institutions. The P/E ratio of Correvio Pharma is -0.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
How much does Correvio Pharma make a year?
Correvio Pharma has a market capitalization of $27.80 million and generates $32.63 million in revenue each year. The company earns $-35.18 million in net income (profit) each year or ($0.79) on an earnings per share basis. How many employees does Correvio Pharma have?
How were Correvio Pharma's earnings last quarter?
Correvio Pharma Corp (NASDAQ:CORV) announced its earnings results on Monday, March, 30th. The company reported ($0.07) earnings per share for the q...
Who are Correvio Pharma's key executives?
Correvio Pharma's management team includes the following people: Dr. Mark H. N. Corrigan , CEO & Director (Age 62) Mr. Justin A. Renz CPA , MST...
Who are some of Correvio Pharma's key competitors?
Some companies that are related to Correvio Pharma include PDS Biotechnology (PDSB) , Anixa Biosciences (ANIX) , Epizyme (EPZM) , Satsuma Pharm...
What other stocks do shareholders of Correvio Pharma own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Correvio Pharma investors own include Inovio Pharmaceutica...
What is Correvio Pharma's stock symbol?
Correvio Pharma trades on the NASDAQ under the ticker symbol "CORV."
What is Correvio Pharma's stock price today?
One share of CORV stock can currently be purchased for approximately $0.42.
How much money does Correvio Pharma make?
Correvio Pharma (NASDAQ:CORV) has a market capitalization of $27.80 million and generates $32.63 million in revenue each year. The company earns $-...
How many employees does Correvio Pharma have?
Correvio Pharma employs 133 workers across the globe.
What is Correvio Pharma's official website?
The official website for Correvio Pharma is www.correvio.com .
Where is Correvio Pharma located?
Is Correvio a pharmaceutical company?
The company was founded in 1986 and is based in Vancouver, Canada.
Barchart Technical Opinion
Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has postponed the reporting of its financial statements and management discussion and analysis (the "2020 Disclosure") in respect of the first quarter ended March 31, 2020 beyond the previous expected date of May 15, 2020. The Company now expects to release its 2020 Disclosure on or before June 29, 2020, subject to the Company ceasing to be a reporting issuer prior to the filing deadline as a result of the Proposed Arrangement (as defined below).
Business Summary
The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.
Golden Star Signal
Correvio Pharma Corp. operates as a pharmaceutical company. It develops and discovers cardiovascular drugs for the treatment of atrial arrhythmia, congestive heart failure and bacterial skin infections. The company's product portfolio includes BRINAVESS (R), AGGRASTAT (R), ESMOCARD (R), ESMOCARDLYO (R),...
Stock Podcast
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Carver Federal Savings Bank to Leverage Moody's Analytics CreditLens Solution to Elevate Customer Experience for its Business Clientele
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
Carver Federal Savings Bank And The Touro Graduate School Of Business Announce Innovative Scholarship Program
Carver Federal Savings Bank ("Carver"), a certified Minority Depository Institution ("MDI"), announced today that it signed an agreement with Moody's Analytics to begin incorporating the power of its CreditLens solutions to improve customer experience and provide enhancements like the ability to apply for credit through a one-click process typically only found at larger institutions.
The Society for Financial Education & Professional Development (SFE&PD) and Carver Bank amplify successful financial education initiative at three historically Black colleges and universities (HBCUs) to include internships and professional development
Carver Federal Savings Bank ("Carver" or the "Bank"), a certified Minority Depository Institution ("MDI"), and the Touro Graduate School of Business ("Touro GSB") announced today an innovative partnership for Carver employees to participate in a fully-paid scholarship program for all graduate certificate and degree programs at the Touro GSB.
Sgoco Surges as Meme Stock Momentum Rages On
Imagine a program where college students learn financial skills and teach their peers knowledge for financial success. The SFE&PD Student Ambassador Program is doing precisely this at Howard University, University of the District of Columbia (UDC), and Medgar Evers College in partnership with Carver Federal Savings Bank ("Carver").
Carver Bancorp (CARV): High Short Interest Sparks Squeeze?
Sgoco shares surge as investors continue to push so-called meme stocks higher on expectations that momentum matters more than fundamentals.
Carver Bancorp Triples in Apparent Meme Stock Boost
Carver Bancorp (CARV) is one of the oldest and largest Black-owned financial institutions in the US. Shares experienced a triple-digit rally on Thursday.
Carver Bancorp and Bank of America Announce Closing of Social Impact Credit Facility with BlackRock
Carver Bancorp shares triple as retail investors rally around the African-American-backed New York financial-services company.
